Showing 26–44 of 44 international scientific journals (Pharmacy)
| Rank | Journal Name & ISSN | Country | WoS Quartile | CAS Division | Impact Factor | Scopus SJR | H-Index | Docs/yr | Self-Citation | Publisher | Profile |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | Expert Opinion on Pharmacotherapy ISSN: 1465-6566 / 1744-7666Top Tier | 🇬🇧United Kingdom | Q2 | CAS Tier 3 | 3.4 | 0.765Q2 | 69 | 166 | 4% | Taylor and Francis Ltd. | Profile |
| 27 | Investigational New Drugs ISSN: 0167-6997 / 1573-0646 | 🇺🇸United States | Q2 | CAS Tier 3 | 3.4 | 0.816Q2 | 80 | 156 | 3.3% | Springer US | Profile |
| 28 | Journal of Managed Care & Specialty Pharmacy ISSN: 2376-0540 / 2376-1032 | 🇺🇸United States | Q2 | CAS Tier 3 | 3.3 | 1.212Q1 | 55 | 162 | 8.7% | Academy of Managed Care Pharmacy (AMCP) | Profile |
| 29 | Journal of Pharmacokinetics and Pharmacodynamics ISSN: 1567-567X / 1573-8744 | 🇺🇸United States | Q2 | CAS Tier 3 | 3.3 | 0.85Q2 | 54 | 61 | 13.6% | Springer US | Profile |
| 30 | Current Pharmaceutical Design ISSN: 1381-6128 / 1873-4286Top Tier | 🇳🇱Netherlands | Q2 | CAS Tier 4 | 3.2 | 0.632Q2 | 140 | 397 | 3.8% | Bentham Science Publishers B.V. | Profile |
| 31 | British Journal of Clinical Pharmacology ISSN: 0306-5251 / 1365-2125 | 🇬🇧United Kingdom | Q2 | CAS Tier 3 | 3 | 1Q1 | 131 | 400 | 3.2% | Wiley-Blackwell Publishing Ltd | Profile |
| 32 | Current Therapeutic Research-Clinical and Experimental ISSN: 0011-393X / 1879-0313 | 🇺🇸United States | Q3 | CAS Tier 4 | 3 | 0.609Q2 | 34 | 30 | 0% | Elsevier Inc. | Profile |
| 33 | Expert Opinion on Drug Safety ISSN: 1474-0338 / 1744-764X | 🇬🇧United Kingdom | Q2 | CAS Tier 3 | 3 | 0.86Q2 | 62 | 160 | 3.3% | Taylor and Francis Ltd. | Profile |
| 34 | Molecular Pharmacology ISSN: 0026-895X / 1521-0111 | 🇺🇸United States | Q2 | CAS Tier 4 | 3 | 1.15Q1 | 186 | 80 | 3.1% | American Society for Pharmacology and Experimental Therapeutics | Profile |
| 35 | Fitoterapia ISSN: 0367-326X / 1873-6971 | 🇳🇱Netherlands | Q3 | CAS Tier 4 | 2.9 | 0.511Q2 | 90 | 217 | 8% | Elsevier | Profile |
| 36 | Pharmaceutical Development and Technology ISSN: 1083-7450 / 1097-9867 | 🇺🇸United States | Q2 | CAS Tier 4 | 2.9 | 0.471Q2 | 50 | 83 | 3.8% | Informa Healthcare | Profile |
| 37 | Journal of Pharmacological Sciences ISSN: 1347-8613 / 1347-8648 | 🇯🇵Japan | Q3 | CAS Tier 3 | 2.8 | 0.891Q2 | 74 | 140 | 3.3% | Japanese Pharmacological Society | Profile |
| 38 | Pharmacogenomics Journal ISSN: 1470-269X / 1473-1150 | 🇺🇸United States | Q2 | CAS Tier 3 | 2.8 | 0.76Q2 | 78 | 56 | 0% | Springer Nature | Profile |
| 39 | Pharmacology ISSN: 0031-7012 / 1423-0313 | 🇨🇭Switzerland | Q3 | CAS Tier 4 | 2.8 | 0.81Q2 | 54 | 78 | 3.4% | S. Karger AG | Profile |
| 40 | Drug Development and Industrial Pharmacy ISSN: 0363-9045 / 1520-5762 | 🇺🇸United States | Q3 | CAS Tier 4 | 2.6 | 0.402Q2 | 78 | 118 | 4.2% | Informa Healthcare | Profile |
| 41 | Journal of Natural Medicines ISSN: 1340-3443 / 1861-0293 | 🇯🇵Japan | Q3 | CAS Tier 4 | 2.6 | 0.482Q2 | 37 | 110 | 12% | Springer Singapore | Profile |
| 42 | Journal of Pharmaceutical Policy and Practice ISSN: 2052-3211 | 🇬🇧United Kingdom | Q2 | CAS Tier 3 | 2.6 | 0.74Q1 | — | 85 | 9.1% | Springer Nature | Profile |
| 43 | Pharmacoepidemiology and Drug Safety ISSN: 1053-8569 / 1099-1557 | 🇬🇧United Kingdom | Q3 | CAS Tier 3 | 2.6 | 1.041Q1 | 85 | 166 | 4.2% | John Wiley and Sons Ltd | Profile |
| 44 | Planta Medica ISSN: 0032-0943 / 1439-0221 | 🇩🇪Germany | Q4 | CAS Tier 4 | 2.1 | 0.456Q2 | 103 | 144 | 4.8% | Georg Thieme Verlag | Profile |